10
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A case of amyloidosis secondary to rheumatoid arthritis complicated with Graves' ophthalmopathy

, , , , , , , , , & show all
Pages 261-264 | Received 08 Jun 2002, Accepted 18 Dec 2002, Published online: 02 Jan 2014

References

  • Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunc-tion in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 1993;52:454–6.
  • Kimura H, Yamashita S, Ashizawa K, Yokoyama N, Nagataki S. Thyroid dysfunction in patients with amyloid goitre. Clin Endocrinol (Oxford) 1997;46:769–74.
  • Ruggeri RM, Galletti M, Mandolfino MG, Aragona P, Bartolone S, Giorgianni G, et al. Thyroid hormone autoantibodies in primary SjOgren's syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease, and becoming progressively more frequent in these diseases. J Endocrinol Invest 2002;25:447–54.
  • Kirkegaard C, Bliddal BH. Thyroid-stimulating antibodies in rheu-matoid arthritis: an in vitro phenomenon. J Endocrinol Invest 1987;10:495–8.
  • Noh JY, Hamada N, Inoue Y, Abe Y, Ito K. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid 2000;10:809–13.
  • Wakelkamp IMMJ, Gerding MN, van der Meer JWC, Prummel MF, Wiersinga WM. Both Thl- and Th2-derived cytokines in se-rum are elevated in Graves' ophthalmopathy. Clin Exp Immunol 2000;121:453–7.
  • Valyasevi RW, Jyonouchi SC, Dutton CM, Munsakul N, Balm RS. Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 2001;86:903–8.
  • Many MC, Costagliola S, Detrait M, Dnenef F, Vassart G, Ludgate MC. Development of an animal model of autoimmune thyroid eye disease. J Immunol 1999;162:4966–74.
  • Olsen NJ, Callahan LF, Brooks RH, Nance EP, Kaye JJ, Stastny P, et al. Associations of HLA-DR4 with rheumatoid factor and ra-diographic severity in rheumatoid arthritis. Am J Med 1988;84: 257–64.
  • Maury CP, Teppo AM, Wafin F, Wegelius 0, Friman C, Koshkimies S, et al. Class-specific rheumatoid factors, DR anti-gens, and amyloidosis in patients with rheumatoid arthritis. Ann Rheum Dis 1988;47:546–52.
  • Farid N, Thompson C. HLA and autoimmune endocrine disease 1985. Mol Biol Med 1986;3:85–97.
  • Dahlberg PA, Holmlund G, Karlsson FA, Safwenberg J. HLA-A, -B, -C, and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Acta Endocrinol (Copenhagen) 1981;97:42–7.
  • Azuma Y, Sakurami T, Ueno Y, Ohishi M, Saji H, Terasaki PI, et al. HLA-DR antigens in Japanese with Hashimoto's thyroiditis and Graves' disease. Endocrinol Jpn 1982;29:423–7.
  • Ohtsuka K, Nakamura Y. Human leukocyte antigens associated with hyperthyroid Graves ophthalmopathy in Japanese patients. Am J Ophthalmol 1998;126:805–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.